WCLC 2025 - Posters & ePosters-P3.18.06 Phase 1b Study of a Novel Fluorescent Imaging Agent, LS301, for Lung Cancer Surgery to Localize Tumors and Assess Margins

P3.18.06 Phase 1b Study of a Novel Fluorescent Imaging Agent, LS301, for Lung Cancer Surgery to Localize Tumors and Assess Margins

Asset Subtitle

Nick Staten

Meta Tag

Speaker Nick Staten

Topic Clinical Trials in Progress